Lancashire and South Cumbria
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-02-02 Sympathomimetics
Ephedrine
Formulary
Nasal drops 0.5%, 1%
If no strength is specified 0.5% drops will be supplied
Xylometazoline
Otrivine
®
Formulary
Nasal drops 0.1%
Nasal spray 0.1%
Paediatric nasal drops 0.05%
Links
LSCMMG: Gastroenterology Biologics Pathway
LSCMMG: Primary Care Constipation Guidelines
MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
NICE CG147: Diverticular disease: diagnosis and management
NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
UKMI Q&A: Drug induced hypersalivation: Treatment options
Key
Full Site